VANCOUVER, British Columbia — August 5, 2026 — Leads & Copy — Rocket Doctor AI Inc. has engaged B2i Digital, Inc. to provide digital marketing advisory services, a move intended to broaden the company’s presence, particularly in the U.S. market. The agreement, pending approval from the Canadian Securities Exchange, will see B2i Digital offer a suite of services focused on investor outreach and brand visibility.
Services provided by B2i Digital will include the development and maintenance of a featured company profile on b2idigital.com, the creation and management of paid digital advertising campaigns, and the production of investor-focused content and creative materials. Additionally, B2i Digital will handle content distribution across various social media channels, execute email marketing campaigns targeting the investing community, and facilitate connections for Rocket Doctor AI with relevant investor conferences and speaking opportunities.
Dr. Essam Hamza, CEO of Rocket Doctor AI, expressed enthusiasm for the collaboration, stating it is a critical component of the company’s strategy to expand its reach. He emphasized that the AI-powered solutions, developed by physicians, aim to serve those in need, with a particular focus on broadening access across the U.S., including New York.
The promotional activities are slated to occur across multiple platforms, including the B2i Digital website, social media channels such as LinkedIn, Facebook, X, Instagram, YouTube, and Reddit, as well as through email newsletters and targeted email marketing campaigns. Paid digital advertising and Webull Corporate Communications are also part of the promotional strategy.
David Shapiro, CEO of B2i Digital, highlighted the careful selection process for companies featured in their program, noting his impression of Rocket Doctor AI’s mission. He stated that the company addresses a significant issue within the U.S. healthcare system, a problem he has personally observed. Shapiro clarified that he does not recommend the purchase of any security but feels compelled to act as a messenger to the markets for Rocket Doctor AI.
The engagement is set for an initial term of three months, commencing upon B2i Digital’s receipt of payment. The promotional activity is expected to begin around August 5, 2026, and conclude approximately three months later. Rocket Doctor AI will pay B2i Digital a total cash fee of $21,375 USD at the start of the agreement. The company also holds an option to extend the term to six months for an additional $14,625 USD, or to twelve months for $32,625 USD, within the first month of the agreement. The agreement will not automatically renew and requires written confirmation from both parties prior to expiry, barring 30 days’ written notice from either side.
B2i Digital, described as an arm’s-length service provider, specializes in connecting public companies with market participants through its proprietary network. Founded in 2021 by David Shapiro, a former investment banker, the firm offers programs such as Featured Conference, Featured Company, and Featured Expert, utilizing its owned media across web, video, social, and email, amplified by newswire syndication.
Rocket Doctor AI Inc. is dedicated to providing physician-built, AI-powered healthcare solutions. Its technology includes the Global Library of Medicine (GLM), a decision support system, and an AI-powered digital health platform that supports physicians in managing their practices and expanding patient access. The company aims to reduce administrative burdens, enhance physician-patient interactions, and serve underserved communities in Canada and patients on Medicaid and Medicare in the U.S.
Source: Rocket Doctor AI Inc.
